Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer

IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer

US Patent 7608696 · Granted Oct 27, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK2 inhibitors and methods of using the same2024
CDK2 inhibitors and methods of using the same2024
Mechanism of resistance to bet bromodomain inhibitors2023
Methods for treating, preventing and predicting risk of developing breast cancer2023
Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical 2020
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Pharmaceutical combinations2018
Gene methylation and expression2017
Pharmaceutical combinations2016
Biomarkers for IAP inhibitor therapy2016
IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer2012
IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer2012